ICU Medical Inc.
161.00
2.85 (1.80%)
At close: Jan 14, 2025, 3:59 PM
161.08
0.05%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 65.2
Market Cap 3.94B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -4.55
PE Ratio (ttm) -35.38
Forward PE n/a
Analyst Buy
Ask 257.72
Volume 92,732
Avg. Volume (20D) 219,226
Open 158.94
Previous Close 158.15
Day's Range 157.58 - 161.66
52-Week Range 86.80 - 196.26
Beta undefined

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for h...

Sector Healthcare
IPO Date Mar 31, 1992
Employees 14,000
Stock Exchange NASDAQ
Ticker Symbol ICUI

Analyst Forecast

According to 4 analyst ratings, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is $200, which is an increase of 24.22% from the latest price.

Buy 75.00%
Hold 25.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

ICU Medical Inc. is scheduled to release its earnings on Feb 25, 2025, during market hours.
Analysts project revenue of $599.10M, reflecting a 1.91% YoY growth and earnings per share of 1.48, making a -5.73% decrease YoY.
5 months ago · Source
+24.27%
ICU Medical shares are trading higher after the co... Unlock content with Pro Subscription